Promentis Pharmaceuticals, a Milwaukee company co-founded by Drs. John Mantsch and David Baker, professors in the Biomedical Sciences Department, raised $26 million, including $17.2 million in its third round of funding. The investment will finance key clinical trials of its most promising compound targeting neuropsychiatric disorders. “This unique compound is one of the first attempts to […]